Calcium signalling and autacoid productionin endothelial cells are modulated by changes in tyrosine kinase and phosphatase activity

Journal of Vascular Research

Volumn 33, Issue 3, 1996, Pages 225-234

  Fleming, Ingrid ^a   Bara, Agnieszka T ^a   Busse, Rudi ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Endothelial cell; Endothelium derived hyperpolarizing factor; Nitric oxide; Tyrosine kinases; Tyrosine phosphatases

Indexed keywords

ARSENOSOBENZENE; AUTACOID; BRADYKININ; DICLOFENAC; DIMERCAPROL; ENDOTHELIUM DERIVED RELAXING FACTOR; ENZYME INHIBITOR; ERBSTATIN; GENISTEIN; NITRIC OXIDE; PHENYLEPHRINE; PHOSPHOTYROSINE; PROSTACYCLIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; VANADATE SODIUM;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION; SWINE; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0030004715     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000159150     Document Type: Article

References (39)

1. Fleming I, Fisslthaler B, Busse R: Calcium signaling in endothelial cells involves activation of tyrosine kinases and leads to activation of MAP kinase, Circ Res 1995;76:522-529.
2. 2' influx and protein tyrosine phosphorylation in endothelial cells is inhibited by herbimycin A, Biochem Biophys RcsCommun 1994:202:1651-1656.
3. 2+ influx in human endothelial cells is controlled by the level of protein tyrosine phosphorylation (abstract), FASEB J 1995:9:A872.
4. Vostal JG, Jackson WL, Shulman NR: Cytosolic and stored calcium antagonistically control tyrosine phosphorylation of specific platelet proteins, J Biol Chem 1991:266:16911-16916.
5. 2+ entry in fura-2-loadcd human platelets, Biochem J 1994;303:337-339.
6. Busse R, Fleming I: The endothelial organ, CurrOpin Cardiol 1993;8:719-727.
7. Luckhoff A, Pohl U, Miilsch A, Busse R: Differential role of extra- and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells, Br J Pharmacol 1988;95:189-196.
8. Busse R, Miilsch A: Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin, FEBS Lett 1990:265: 133-136.
9. Hong SL, Dcvkin D: Activation of phospholi-pascs A; and C in pig aortic endothelial cells synthesizing prostacyclin, J Biol Chem 1982: 257:7151-7154.
10. Busse R, Lamontagne D: Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells, Naunyn Schmiedebcrgs Arch Pharmacol 1991: 344:126-129.
11. Fleming I, Hecker M, Busse R: Intracellular alkalinization induced by bradykinin sustains activation of the constitutive nitric oxide synthase in endothelial cells, Circ Res 1994:74: 1220-1226.
12. 2+ indicators with greatly improved fluorescence properties, J Biol Chem 1985:60:3440-3450
13. Wicmcr G, Scholkcns BA, Becker RHA, Busse R: Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothe-lium-dcrived bradvkinin, Hvpertension 1991: 18:558-563.
14. Bauersachs J, Hecker M, Busse R: Display of the characteristics of endothelium-derived hy-perpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation, BrJ Pharmacol 1994: 113:1548-1553.
15. c-src kinase by middle-T antigen binding or by dcphospho-rylation, EM BO J 1985:4:1471-1477.
16. c-src, Mol Cell Biol 1988:8: 4541-4546.
17. Imben V, Pevron J-F, Farahi Far D, Mari B, Aubergcr P, Rossi B: Induction of tyrosine phosphorylation and T-ccll activation by vanadate peroxide, an inhibitor of protein tyrosine phosphatases, Biochem J 1994;297:163-173.
18. Kumada T, Nakashinta S, Miyata H, Nozawa Y: Potent activation of phospholipasc D by phenv'arsine oxide in rat basophilic leukemia (RBL-2H3) cells, Biochem Biophys Res Com-mun 1994:199:792-798.
19. 2+ mobilization, Immunol Lett 1995:44:149-156.
20. Rozsnyay Z, Sarmav G, Gergely J: Phenvlar-sine oxide (PAO) blocks antigen receptor-induced calcium response and tyrosine phosphorylation of a distinct group of proteins, Immunol Lett 1993:37:197-205.
21. Fletcher MO, Samelson LE, June CH: Complex effects of phenylarsine oxide in T cells, J Biol Chem 1993:268:23697-23703.
22. Yang J, Clark AE, Harrison R, Kozka IJ, Holman GD: T rafficking of glucose transporters in 3T3-LI cells, BiochemJ 1992:281:809-817.
23. Jhun BH, Hah JS, Jung CY: Phenylarsine oxide causes an insulin-dependent, GLUT4-spe-cific degradation in rat adipocytes, J Biol Chem 1991:266:22260-22265.
24. Frost SC, Lane MD, Gibbs EM: Effect of phenylarsine oxide on fluid phase endocytosis: Further evidence for activation of the glucose transporter, J Cell Physiol 1989:141:467-474.
25. Medema RH, Burgcring BMT, Bos JL: Insulin-induced p21ras activation docs not require protein kinase C, but a protein sensitive to phenylarsine oxide, J Biol Chem 1991:266:21186- 21189.
26. Le Cabec V, Maridonncau-Parini I: Complete and reversible inhibition of NADPH oxidase in human neutrophils by phenylarsine oxide at a step distal to membrane translocation of the cnzvmc subunits, J Biol Chem 1995:270:2067-2073.
27. Casclli A, Camici G, Manao G, Moneti G, Paz-zagli L, Cappugi G, Ramponi G: Nitric oxide causes inactivation of the low molecular weight phosphotvrosine protein phosphatase, J Biol Chem 1994:269:24878-24882.
28. Peranovich TMS, Da Silva AM, Fries DM, Stern A, Montciro HP: Nitric oxide stimulates tyrosine phosphory lation in murine fibroblasts in the absence and presence of epidermal growth factor, BiochemJ 1995:305:613-619.
29. Steinberg HO, Brcchtel G, Johnson A, Fine-berg N, Baron AD: Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent, J Clin Invest 1994:94:1172-1179.
30. Scherrer U, Randin D, Vollenweider P, Vollen-weider L, Nicod P: Nitric oxide release accounts for insulin’s vascular effects in humans, J Clin Invest 1994:94:2511-2515.
31. Kasuga M, Fujita-Yamaguchi Y, Blithe D, Kahn CR: Tyrosine-specific protein kinase activity is associated with the purified insulin receptor, Proc Natl Acad Sci USA 1983:80: 2137-2141.
32. Roth RA, Cassell DT: Insulin receptor: Evidence that it is a protein kinase, Science 1983: 219:299-301.
33. Kasuga M, Izumi T, Tobe K, Shiba T, Momo-mura K, Tashiro-Hashimoto Y, Kadowaki T: Substrates for insulin receptor kinase, Diabetes Care 1990;13:317-326.
34. Rosen OM: After insulin binds, Science 1987; 237:1452-1457.
35. Carey JO, Azevedo JI Jr., Morris PG, Pories WJ, Dohm GL: Okadaic acid, vanadate, and phenylarsine oxide stimulate 2-deoxyglucose transport in insulin-resistant human skeletal muscle, Diabetes 1995:44:682-688.
36. Oyama Y, Kawasaki H, Hattori Y, Kanno M: Attenuation of endothelium-dependent relaxation in aorta from diabetic rats, Eur J Pharmacol 1986:131:75-78.
37. Calver A, Collier J, Vallance P: Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes, J Clin Invest 1992:90: 2548-2554.
38. Craven PA, Studer RK, DeRubertis FR: Impaired nitric oxide release by glomeruli from diabetic rats, Metabolism 1995:44:695-698.
39. Colas B, Cambillau C, Buscail L, Zeggari M, Esteve JP, Lautrc V, Thomas F, Vayssc N, Susini C: Stimulation of a membrane tyrosine phosphatase activity by somatostatin analogues in rat pancreatic acinar cells, Eur J Bio-chem 1992:207:1017-1024